World Leading Speakers

 

Kate Adcock, Director Of Research And Innovation, The Muscular Dystrophy U.K.

Kate Adcock | Director Of Research And Innovation | The Muscular Dystrophy U.K. » speaking at PPMA 2020

Ion Agirrezabal, Senior Consultant, Covance Market Access And Phase Iv Solutions, Covance Market Access

Ion Agirrezabal | Senior Consultant, Covance Market Access And Phase Iv Solutions | Covance Market Access » speaking at PPMA 2020

Tanya Aiden, Global Products Lead, BIOCAD

Tanya Aiden | Global Products Lead | BIOCAD » speaking at PPMA 2020

John Alter, Vice President Pricing And Market Access, Pfizer

John Alter | Vice President Pricing And Market Access | Pfizer » speaking at PPMA 2020

Mauricio Alvarez Reyes, Independent, Independent

Mauricio Alvarez Reyes | Independent | Independent » speaking at PPMA 2020

Sofie Alverlind, Project Manager, Swedish Association of Local Authorities and Regions

Ines Alves, President, ANDO Portugal

Ines Alves | President | ANDO Portugal » speaking at PPMA 2020

Einar Andreassen, Senior Adviser, Hta And Reimbursement, Norwegian Medicines Agency

Einar Andreassen | Senior Adviser, Hta And Reimbursement | Norwegian Medicines Agency » speaking at PPMA 2020

Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Diego Ardigo | R&D Rare Diseases Unit Head | Chiesi Farmaceutici SpA » speaking at PPMA 2020

Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, NIHDI - INAMI Belgium

Francis Arickx | Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy | NIHDI - INAMI Belgium » speaking at PPMA 2020

Ramesh Arjunji, Senior Director Heor And Rwe, AveXis

Ramesh Arjunji | Senior Director Heor And Rwe | AveXis » speaking at PPMA 2020

Nadeem Ashraf, Medical Advisor - Diabetes, N/A

Kagan Atikeler, Researcher, Utrecht University

Kagan Atikeler | Researcher | Utrecht University » speaking at PPMA 2020

Dorthe Bartels, Strategic Adviser, Amgros

Dorthe Bartels | Strategic Adviser | Amgros » speaking at PPMA 2020

Alex Bastian, Vice President, Value And Market Access, Galapagos NV

Alex Bastian | Vice President, Value And Market Access | Galapagos NV » speaking at PPMA 2020

Ulrike Beckert, Senior Patient Access Manager Dach, Sobi - Swedish Orphan Biovitrum AB (publ)

Ulrike Beckert | Senior Patient Access Manager Dach | Sobi - Swedish Orphan Biovitrum AB (publ) » speaking at PPMA 2020

Antje Behring, Acting Head, Federal Joint Committee

Antje Behring | Acting Head | Federal Joint Committee » speaking at PPMA 2020

Igor Beitia Ortiz De Zárate, Director Market Access Southern Europe Region, PTC Therapeutics

Igor Beitia Ortiz De Zárate | Director Market Access Southern Europe Region | PTC Therapeutics » speaking at PPMA 2020

Tatyana Benisheva, Professor In Drug Regulatory Affairs, Bulgarian Association For Drug Information

Tatyana Benisheva | Professor In Drug Regulatory Affairs | Bulgarian Association For Drug Information » speaking at PPMA 2020

Niri Bhimsan, Head - Health Technology Assessment, Discovery Health

Niri Bhimsan | Head - Health Technology Assessment | Discovery Health » speaking at PPMA 2020

Nadia Bodkin, Rare Disease Advocacy Professional, Rare Advocacy Movement

Nadia Bodkin | Rare Disease Advocacy Professional | Rare Advocacy Movement » speaking at PPMA 2020

Axel Boehnke, Director Market Access Eu North, PTC Therapeutics

Axel Boehnke | Director Market Access Eu North | PTC Therapeutics » speaking at PPMA 2020

Luc Boileau, Chairman And Chief Executive Officer, INESSS

Luc Boileau | Chairman And Chief Executive Officer | INESSS » speaking at PPMA 2020

Trishal Boodhna, Senior Health Economist, Consulting at McCann Health

Trishal Boodhna | Senior Health Economist | Consulting at McCann Health » speaking at PPMA 2020

Hassan Bruneo, Associate Director, Alnylam Switzerland Gmbh

Hassan Bruneo | Associate Director | Alnylam Switzerland Gmbh » speaking at PPMA 2020

Anna Bucsics, Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)

Anna Bucsics | Project Advisor | Mechanism of Coordinated Access to orphan medicinal products (MoCA) » speaking at PPMA 2020

Rob Burley, Director Of Campaigns, Care And Support, The Muscular Dystrophy U.K.

Rob Burley | Director Of Campaigns, Care And Support | The Muscular Dystrophy U.K. » speaking at PPMA 2020

Nicki Catterick, Senior Director, Global Market Access And Pricing, Merck Group

Nicki Catterick | Senior Director, Global Market Access And Pricing | Merck Group » speaking at PPMA 2020

David Catterick, Head Of Market Access Uk, Amgen

David Catterick | Head Of Market Access Uk | Amgen » speaking at PPMA 2020

Sandro Cesaro-Tadic, Head Pricing I8 And Product Pricing Strategies, Roche

Sandro Cesaro-Tadic | Head Pricing I8 And Product Pricing Strategies | Roche » speaking at PPMA 2020

Mark Chalmers, Director, Navigant – A Guidehouse Company

Mark Chalmers | Director | Navigant – A Guidehouse Company » speaking at PPMA 2020

Francesca Cook, Senior Director, Global Head Of Pricing And Market Access, Regenxbio

Francesca Cook | Senior Director, Global Head Of Pricing And Market Access | Regenxbio » speaking at PPMA 2020

Catherine Coulouvrat, Health Value Translation Director, R&D, Sanofi

Catherine Coulouvrat | Health Value Translation Director, R&D | Sanofi » speaking at PPMA 2020

Warren Cowell, Market Access Director, Shionogi Inc

Warren Cowell | Market Access Director | Shionogi Inc » speaking at PPMA 2020

Francis Crawley, Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer), Good Clinical Practice Alliance (GCPA)

Francis Crawley | Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer) | Good Clinical Practice Alliance (GCPA) » speaking at PPMA 2020

Alan Crowther, General Manager, EVERSANA

Alan Crowther | General Manager | EVERSANA » speaking at PPMA 2020

Marcin Czech, Former Vice Minister, Ministry of Health Poland

Marcin Czech | Former Vice Minister | Ministry of Health Poland » speaking at PPMA 2020

Omar Dabbous, Vice President, Health Economics And Outcomes Research, AveXis

Omar Dabbous | Vice President, Health Economics And Outcomes Research | AveXis » speaking at PPMA 2020

Charles De Cidrac, Director Of Health Insurance, AXA

Charles De Cidrac | Director Of Health Insurance | AXA » speaking at PPMA 2020

Erwin De Cock, Principal, Late Stage, Syneos Health

Gerard De Pouvourville, Professor And Chairman, Health Economics And Management, ESSEC Business School

Gerard De Pouvourville | Professor And Chairman, Health Economics And Management | ESSEC Business School » speaking at PPMA 2020

Rob De With, Head of Rare Diseases for Europe and Canada, Takeda

Rob De With | Head of Rare Diseases for Europe and Canada | Takeda » speaking at PPMA 2020

Carla Deakin, Programme Director - Commercial And Managed Access, NICE

Carla Deakin | Programme Director - Commercial And Managed Access | NICE » speaking at PPMA 2020

Olga Diachenko, Market Access Manager Europe, Accord Healthcare

Olga Diachenko | Market Access Manager Europe | Accord Healthcare » speaking at PPMA 2020

Valentin Dodonov, Deputy General Head Of Market Access, BIOCAD

Valentin Dodonov | Deputy General Head Of Market Access | BIOCAD » speaking at PPMA 2020

Mark Duman, Nw Service Champion, Diabetes U.K.

Mark Duman | Nw Service Champion | Diabetes U.K. » speaking at PPMA 2020

Jenny Ebert, National Account Director, Genzyme Sanofi Corp

Jenny Ebert | National Account Director | Genzyme Sanofi Corp » speaking at PPMA 2020

David Elvira, Heads Eu Public Affairs, Sanofi

David Elvira | Heads Eu Public Affairs | Sanofi » speaking at PPMA 2020

Gottfried Endel, Ebm, Hta Team Leader, Austrian Social Insurance

Gottfried Endel | Ebm, Hta Team Leader | Austrian Social Insurance » speaking at PPMA 2020

Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband

Michael Ermisch | Specialist, Department Of Pharmaceuticals | G.K.V. Spitzenverband » speaking at PPMA 2020

Jaime Espin, Professor, Andalusian School Of Public Health

Jaime Espin | Professor | Andalusian School Of Public Health » speaking at PPMA 2020

Gina Ewy, Head Of Global Market Access, Hansa Biopharma

Gina Ewy | Head Of Global Market Access | Hansa Biopharma » speaking at PPMA 2020

Valerie Faillat, Head Of Sanofi Espoir Foundation, Sanofi

Valerie Faillat | Head Of Sanofi Espoir Foundation | Sanofi » speaking at PPMA 2020

Diar Fattah, Global Director, Innovative Value Strategies And Evidence (Respiratory), AstraZeneca

Diar Fattah | Global Director, Innovative Value Strategies And Evidence (Respiratory) | AstraZeneca » speaking at PPMA 2020

Girisha Fernando, Chief Executive Officer, Lyfegen HealthTech AG

Girisha Fernando | Chief Executive Officer | Lyfegen HealthTech AG » speaking at PPMA 2020

Conrad Fischer, Medical Director, Intercept Pharmaceuticals Inc

Conrad Fischer | Medical Director | Intercept Pharmaceuticals Inc » speaking at PPMA 2020

Steven Flostrand, Senior Director Of Pricing And Market Access, Celgene

Steven Flostrand | Senior Director Of Pricing And Market Access | Celgene » speaking at PPMA 2020

Douglas Foerster, Head Market Access Europe And Row, Santhera

Douglas Foerster | Head Market Access Europe And Row | Santhera » speaking at PPMA 2020

Jonathan Galduf, Market Access Manager, Sun Pharmaceutical Industries Limited

Jonathan Galduf | Market Access Manager | Sun Pharmaceutical Industries Limited » speaking at PPMA 2020

Benjamin Gannon, Vice President International Access, Policy And Advocacy, Myriad genetics

Benjamin Gannon | Vice President International Access, Policy And Advocacy | Myriad genetics » speaking at PPMA 2020

Sandra Garitonandía, Business Development Manager, Vistex

Oliver Gassner, Head G4A Digital Health Intelligence Emea, Bayer

Oliver Gassner | Head G4A Digital Health Intelligence Emea | Bayer » speaking at PPMA 2020

Katrien Van Geyt, Head Of Market Access, Belgium And Luxembourg, Takeda

Katrien Van Geyt | Head Of Market Access, Belgium And Luxembourg | Takeda » speaking at PPMA 2020

Fabrizio Gianfrate, Professor Of Health Economics, Market Access Advisor, Universities of Rome and Ferrara

Fabrizio Gianfrate | Professor Of Health Economics, Market Access Advisor | Universities of Rome and Ferrara » speaking at PPMA 2020

Josie Godfrey, Director, JG Zebra Consulting

Josie Godfrey | Director | JG Zebra Consulting » speaking at PPMA 2020

Wim Goettsch, Special Hta-Advisor, Zorginstituut

Wim Goettsch | Special Hta-Advisor | Zorginstituut » speaking at PPMA 2020

Alex Grosvenor, Vice President, Global Pricing and Market Access, Precision Xtract

Alex Grosvenor | Vice President, Global Pricing and Market Access | Precision Xtract » speaking at PPMA 2020

Marcus Guardian, Chief Operating Officer, EUnetHTA

Marcus Guardian | Chief Operating Officer | EUnetHTA » speaking at PPMA 2020

Clare Hague, Therapy Area Market Access Lead, Hematology, Janssen Pharmaceutical

Clare Hague | Therapy Area Market Access Lead, Hematology | Janssen Pharmaceutical » speaking at PPMA 2020

Alfred Harvey, Associate Director, Health Economics And Outcomes Research, Becton Dickinson

Alfred Harvey | Associate Director, Health Economics And Outcomes Research | Becton Dickinson » speaking at PPMA 2020

Adam Heathfield, Senior Director Of Global Health And Value Innovation Centre, Pfizer Ltd

Adam Heathfield | Senior Director Of Global Health And Value Innovation Centre | Pfizer Ltd » speaking at PPMA 2020

Ezequiel Heredia, Consultant, Lifescience Dynamics Ltd

Ezequiel Heredia | Consultant | Lifescience Dynamics Ltd » speaking at PPMA 2020

Ramon Hernandez Vecino, Head Of Real World Evidence Data And Analytics Engagement Lead Randd, Sanofi

Ramon Hernandez Vecino | Head Of Real World Evidence Data And Analytics Engagement Lead Randd | Sanofi » speaking at PPMA 2020

Hans Hofstraat, Vice President, Philips Research

Hans Hofstraat | Vice President | Philips Research » speaking at PPMA 2020

Stefan Holmstrom, Head, Hta Strategy And Pro Excellence, Astellas Pharma

Stefan Holmstrom | Head, Hta Strategy And Pro Excellence | Astellas Pharma » speaking at PPMA 2020

Birgit Holz, Global Head Of Contracting Innovation, Sanofi

Birgit Holz | Global Head Of Contracting Innovation | Sanofi » speaking at PPMA 2020

Francois Houyez, Treatment Information And Access Director, Health Policy Advisor, EURORDIS

Francois Houyez | Treatment Information And Access Director, Health Policy Advisor | EURORDIS » speaking at PPMA 2020

Alison Howell, Director, Covance

Wills Hughes-Wilson, Head Of Patient Access And Commercial Planning, Mereo BioPharma

Ulrike Jacobi, Head Of External Affairs And Market Access, Amgen

Ulrike Jacobi | Head Of External Affairs And Market Access | Amgen » speaking at PPMA 2020

Ashley Jaksa, Vice President Of Analytics Solutions, Aetion, Inc.

Ashley Jaksa | Vice President Of Analytics Solutions | Aetion, Inc. » speaking at PPMA 2020

Rasmus Jensen, Global Head Of Market Access, Camurus

Rasmus Jensen | Global Head Of Market Access | Camurus » speaking at PPMA 2020

Elizabeth Johnson, Biologics Coordinator, Allergy Partners, P.A.

Elizabeth Johnson | Biologics Coordinator | Allergy Partners, P.A. » speaking at PPMA 2020

Calum Jones, Senior Consultant - Evidence, Value And Access (Heor), Consulting at McCann Health

Calum Jones | Senior Consultant - Evidence, Value And Access (Heor) | Consulting at McCann Health » speaking at PPMA 2020

Rosemary Jose, Director And Commercial Lead, Strategic Market Access, Pharmerit International

Navin Joshi, Global Head Of Pricing, Classic And Established Products. Global Pharma, Head Of Pricing And Access Capabilities, Emerging Marke, GlaxoSmithKline

Navin Joshi | Global Head Of Pricing, Classic And Established Products. Global Pharma, Head Of Pricing And Access Capabilities, Emerging Marke | GlaxoSmithKline » speaking at PPMA 2020

Sven Jungmann, Co-Founder, FoundersLane

Sven Jungmann | Co-Founder | FoundersLane » speaking at PPMA 2020

Marcela Junqueira, Oncology Market Access DIrector - Latin America, Janssen Pharmaceutical

Marcela Junqueira | Oncology Market Access DIrector - Latin America | Janssen Pharmaceutical » speaking at PPMA 2020

Madhusudan Kabra, Director, Evidence Generation, Otsuka Pharmaceutical

Madhusudan Kabra | Director, Evidence Generation | Otsuka Pharmaceutical » speaking at PPMA 2020

Gomathi Kaliappan, Global Market Access - Health Systems Strategy, Value Recognition, Roche

Gomathi Kaliappan | Global Market Access - Health Systems Strategy, Value Recognition | Roche » speaking at PPMA 2020

Lisette Kaskens, Senior Global Market Access Manager, Advanced Accelerator Applications

Lisette Kaskens | Senior Global Market Access Manager | Advanced Accelerator Applications » speaking at PPMA 2020

Diane Kleinermans, Advisor To The Ministry Of Health And Social Affairs, Belgian Federal Government

Diane Kleinermans | Advisor To The Ministry Of Health And Social Affairs | Belgian Federal Government » speaking at PPMA 2020

Alison Kneen, SVP & Head of DRG Abacus, Decision Resources Group

Alison Kneen | SVP & Head of DRG Abacus | Decision Resources Group » speaking at PPMA 2020

Jolanda Koenders, Head Of Patient Value And Access, Takeda

Jolanda Koenders | Head Of Patient Value And Access | Takeda » speaking at PPMA 2020

Shanthy Krishnaraja, Senior Director, Market Access And Strategy, Seqirus

Shanthy Krishnaraja | Senior Director, Market Access And Strategy | Seqirus » speaking at PPMA 2020

Adam Kundzewicz, Senior Global Payer Strategy Manager, Head Of Pricing, Boehringer Ingelheim Pharma GmbH & Co. KG

Dylan Lamb-Palmer, Manager, Pricing and Data Analytics, PDCI Market Access Inc

Marie-Liesse Le Corfec, Global Portfolio Marketing Head, Ps, B.D. Pharmaceuticals Systems

Marie-Liesse Le Corfec | Global Portfolio Marketing Head, Ps | B.D. Pharmaceuticals Systems » speaking at PPMA 2020

Jost Leemhuis, Head Of Safety Science, Roche

Jost Leemhuis | Head Of Safety Science | Roche » speaking at PPMA 2020

Timothy Lenehan, Senior Director - Global Value And Access, Biogen

Timothy Lenehan | Senior Director - Global Value And Access | Biogen » speaking at PPMA 2020

Giovanny Leon, P&Ma Director, Novartis AG

Giovanny Leon | P&Ma Director | Novartis AG » speaking at PPMA 2020

Bruno Leroy, Vice President, Global Head Of Health Value Translation, Sanofi

Bruno Leroy | Vice President, Global Head Of Health Value Translation | Sanofi » speaking at PPMA 2020

Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer

Friedhelm Leverkus | Director Health Technology Assessment And Outcomes Research | Pfizer » speaking at PPMA 2020

Nanxin Li, Senior Director and Head, Health Economics and Outcomes Research (HEOR), uniQure

Nanxin Li | Senior Director and Head, Health Economics and Outcomes Research (HEOR) | uniQure » speaking at PPMA 2020

Herve Lilliu, Chief Executive Officer, inbeeo

Herve Lilliu | Chief Executive Officer | inbeeo » speaking at PPMA 2020

Sune Lindgaard, Chief Of Business Intelligence, Amgros, Denmark

Sune Lindgaard | Chief Of Business Intelligence | Amgros, Denmark » speaking at PPMA 2020

Yannick Loonus, Chief Sales Officer, Semalytix GmbH

Catarina Lopes Pereira, Global Market Access Manager, Medac

Catarina Lopes Pereira | Global Market Access Manager | Medac » speaking at PPMA 2020

Kevin Loth, Vice President, Corporate Affairs And Policy, Worldwide Markets, Celgene

Kevin Loth | Vice President, Corporate Affairs And Policy, Worldwide Markets | Celgene » speaking at PPMA 2020

Elena Lungu, Manager Of Policy Development, Government of Canada (Canada)

Elena Lungu | Manager Of Policy Development | Government of Canada (Canada) » speaking at PPMA 2020

Alastair Macdonald, Senior Vice President Of Real World And Late Phase, Syneos Health

Alastair Macdonald | Senior Vice President Of Real World And Late Phase | Syneos Health » speaking at PPMA 2020

Mark Macgregor, Medical Director, Golden Jubilee National Hospital

Mark Macgregor | Medical Director | Golden Jubilee National Hospital » speaking at PPMA 2020

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen | Medical Director | Norwegian Medicines Agency, Norway » speaking at PPMA 2020

Joerg Mahlich, Heor, Janssen Pharmaceutical K.K.

Andrea Mantovani, Former Market Access Executive, Independent

Andrea Mantovani | Former Market Access Executive | Independent » speaking at PPMA 2020

Marco Marchetti, Director Of The National Center For Health Technology Assessment, Istituto Superiore di Sanita

Marco Marchetti | Director Of The National Center For Health Technology Assessment | Istituto Superiore di Sanita » speaking at PPMA 2020

Anne Marciniak, Head Of Market Access, Europe, Aimmune

Anne Marciniak | Head Of Market Access, Europe | Aimmune » speaking at PPMA 2020

Cristina Martin-Rinconada, Head Of Value And Access For International Partners Markets (Mena And Ceer Regions), Biogen

Cristina Martin-Rinconada | Head Of Value And Access For International Partners Markets (Mena And Ceer Regions) | Biogen » speaking at PPMA 2020

Vipul Modi, Head Of Transformation For Innovation, Digital And Life Sciences, Oxford Academic Health Science Network

Vipul Modi | Head Of Transformation For Innovation, Digital And Life Sciences | Oxford Academic Health Science Network » speaking at PPMA 2020

Patrick Mollon, Heor Consultant, Gmap, Ipsen Pharma

Patrick Mollon | Heor Consultant, Gmap | Ipsen Pharma » speaking at PPMA 2020

Paolo Morgese, Director, Market Access And Member Relations, Alliance for Regenerative Medicine

Thomas Mueller, Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology, Federal Ministry of Health Germany

Thomas Mueller | Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology | Federal Ministry of Health Germany » speaking at PPMA 2020

Michael Muller, Head Of Market Access, Western Europe, Sun Pharma

Michael Muller | Head Of Market Access, Western Europe | Sun Pharma » speaking at PPMA 2020

Diane Munch, Vice President, Global Pricing, Patient And Health Impact, Pfizer

Diane Munch | Vice President, Global Pricing, Patient And Health Impact | Pfizer » speaking at PPMA 2020

Anushini Muthutantri, Director, Evidence, Value And Access, Consulting at McCann Health

Anushini Muthutantri | Director, Evidence, Value And Access | Consulting at McCann Health » speaking at PPMA 2020

Sue Naeyaert, Advisor, Independent

Sue Naeyaert | Advisor | Independent » speaking at PPMA 2020

Hanadi Nahas, Chairman And General Manager, Access Core

Hanadi Nahas | Chairman And General Manager | Access Core » speaking at PPMA 2020

Inez Naidu, Head - Discovery Health Medicines Unit, Discovery Health

Inez Naidu | Head - Discovery Health Medicines Unit | Discovery Health » speaking at PPMA 2020

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Alexander Natz | Secretary General | European Confederation of Pharmaceutical Entrepreneurs (Belgium) » speaking at PPMA 2020

Noluthando Nematswerani, Head - Centre For Clinical Excellence, Discovery Health

Noluthando Nematswerani | Head - Centre For Clinical Excellence | Discovery Health » speaking at PPMA 2020

Claudia Neuber, Head Of Global Pricing Implementation, AstraZeneca

Claudia Neuber | Head Of Global Pricing Implementation | AstraZeneca » speaking at PPMA 2020

Enkeleida Nikai, Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea), Janssen Pharmaceutical

Enkeleida Nikai | Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea) | Janssen Pharmaceutical » speaking at PPMA 2020

Irina Odnoletkova, Vice President Health Technology Assessment, Apogenix Gmbh

Irina Odnoletkova | Vice President Health Technology Assessment | Apogenix Gmbh » speaking at PPMA 2020

Dapo Ogunbayo, Programme Manager - Healthcare Innovations (Pharmaceuticals), NIHR Innovation Observatory, Newcastle University

Dapo Ogunbayo | Programme Manager - Healthcare Innovations (Pharmaceuticals) | NIHR Innovation Observatory, Newcastle University » speaking at PPMA 2020

Melvin Olson, Global Head Rwd Strategy And Innovation, Novartis Pharma

Melvin Olson | Global Head Rwd Strategy And Innovation | Novartis Pharma » speaking at PPMA 2020

Amer Omar, Senior Director, Lupin

Amer Omar | Senior Director | Lupin » speaking at PPMA 2020

Nneka Onwudiwe, Founder And Chief Executive Officer, Pharmaceutical Economics Consultants of America (PECA) LLC

Nneka Onwudiwe | Founder And Chief Executive Officer | Pharmaceutical Economics Consultants of America (PECA) LLC » speaking at PPMA 2020

Mario Ouwens, Senior Statistical Science Director, Astra Zeneca

Mario Ouwens | Senior Statistical Science Director | Astra Zeneca » speaking at PPMA 2020

Sandra Paci, Director Market Access Europe, Argenx

Sandra Paci | Director Market Access Europe | Argenx » speaking at PPMA 2020

Ana Palma, Senior Director Global Hta And Patient Access Lead, Sobi

Ana Palma | Senior Director Global Hta And Patient Access Lead | Sobi » speaking at PPMA 2020

Elena Panitti, Global Rwe Capability Building Lead, Novartis

Elena Panitti | Global Rwe Capability Building Lead | Novartis » speaking at PPMA 2020

Detlev Parow, Head Pharmaceutical Department, D.A.K.

Detlev Parow | Head Pharmaceutical Department | D.A.K. » speaking at PPMA 2020

Chris Pashos, Former Vice President Of Global Evidence Strategy, AbbVie

Chris Pashos | Former Vice President Of Global Evidence Strategy | AbbVie » speaking at PPMA 2020

Julien Patris, Associate Director Of Market Access And Policy For Europe And Canada, Alnylam

Julien Patris | Associate Director Of Market Access And Policy For Europe And Canada | Alnylam » speaking at PPMA 2020

Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim

Marco Penske | Head Of Market Access And Health Care Affairs | Boehringer-Ingelheim » speaking at PPMA 2020

Ed Pezalla, Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy, Aetna; a CVS Pharmacy Health Company

Ed Pezalla | Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy | Aetna; a CVS Pharmacy Health Company » speaking at PPMA 2020

Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.

Andres Pichon Riviere | Executive Director And Director Of Health Technology Assessment And Economic Evaluations | I.E.C.S. » speaking at PPMA 2020

Sagie Pillay, Chief Operating Officer, Wits Health Consortium

Sagie Pillay | Chief Operating Officer | Wits Health Consortium » speaking at PPMA 2020

Oresta Piniazhko, Director, Hta Department, Ministry of Health of Ukraine

Oresta Piniazhko | Director, Hta Department | Ministry of Health of Ukraine » speaking at PPMA 2020

Carme Pinyol, Head Of Pricing And Market Access Southern Europe, Pierre Fabre

Carme Pinyol | Head Of Pricing And Market Access Southern Europe | Pierre Fabre » speaking at PPMA 2020

Lara Pippo, Head Of Market Access, CSL Behring

Lara Pippo | Head Of Market Access | CSL Behring » speaking at PPMA 2020

Sarah Pitluck, Head, Global Pricing And Reimbursement, Spark Therapeutics

Sarah Pitluck | Head, Global Pricing And Reimbursement | Spark Therapeutics » speaking at PPMA 2020

Adam Plich, Managing Director, Plich Advisory

Adam Plich | Managing Director | Plich Advisory » speaking at PPMA 2020

Mary Lynne Van Poelgeest-Pomfret, President, President of the World Federation for Incontinence and Pelvic Pain - WFIP

Mary Lynne Van Poelgeest-Pomfret | President | President of the World Federation for Incontinence and Pelvic Pain - WFIP » speaking at PPMA 2020

Angelina Irizari Policarpio, Head Of Heor And Real World Evidence Communications, Eisai

Angelina Irizari Policarpio | Head Of Heor And Real World Evidence Communications | Eisai » speaking at PPMA 2020

Caridad Pontes, Manager Of Pharmacotherapeutic Harmonization, Catalan Health Service

Caridad Pontes | Manager Of Pharmacotherapeutic Harmonization | Catalan Health Service » speaking at PPMA 2020

Diann Potestio, Vice President Market Access, Ascendis Pharma

Diann Potestio | Vice President Market Access | Ascendis Pharma » speaking at PPMA 2020

Nuno Prego Ramos, Chief Executive Officer, CellmAbs

Nuno Prego Ramos | Chief Executive Officer | CellmAbs » speaking at PPMA 2020

Marco Rauland, Vice President Global Market Access & Pricing Core Medicines Franchises, Merck Group

Isabell Remus, Head Biopharmaceuticals Europe, Sandoz

Isabell Remus | Head Biopharmaceuticals Europe | Sandoz » speaking at PPMA 2020

Andreia Ribeiro, Director, Lifescience Dynamics Ltd

Andreia Ribeiro | Director | Lifescience Dynamics Ltd » speaking at PPMA 2020

Kevin Rieger, Head Of Public And Governmental Affairs Dach, Ipsen Pharma Gmbh

Kevin Rieger | Head Of Public And Governmental Affairs Dach | Ipsen Pharma Gmbh » speaking at PPMA 2020

Giuseppe Rosano, Member Of The Cardiovascular Working Party, European Medicines Agency

Giuseppe Rosano | Member Of The Cardiovascular Working Party | European Medicines Agency » speaking at PPMA 2020

Micah Rose, Senior Scientific Adviser, Health Economic Modelling, National Institute for Health and Care Excellence

Micah Rose | Senior Scientific Adviser, Health Economic Modelling | National Institute for Health and Care Excellence » speaking at PPMA 2020

Igor Rudychev, Head Of Us Digital, Data, And Innovations, AstraZeneca

Igor Rudychev | Head Of Us Digital, Data, And Innovations | AstraZeneca » speaking at PPMA 2020

Marcelo Sal, Head of Market Access and Pricing, Argentina, PTC Therapeutics

Marcelo Sal | Head of Market Access and Pricing, Argentina | PTC Therapeutics » speaking at PPMA 2020

Yves Samel, Market Access Strategy Leader And Global Pricing Manager, Bayer

Yves Samel | Market Access Strategy Leader And Global Pricing Manager | Bayer » speaking at PPMA 2020

Steve Sandor, Vice President, Market Access And Trade, Paratek Pharmaceuticals , Inc.

Steve Sandor | Vice President, Market Access And Trade | Paratek Pharmaceuticals , Inc. » speaking at PPMA 2020

Gustavo Saraiva Dos Anjos, Global Market Access Director For Biologics, GlaxoSmithKline

Gustavo Saraiva Dos Anjos | Global Market Access Director For Biologics | GlaxoSmithKline » speaking at PPMA 2020

Michael Schroter, Partner, Viopas Partners

Michael Schroter | Partner | Viopas Partners » speaking at PPMA 2020

Mitch Scurtu, President, Global Technologies

Mitch Scurtu | President | Global Technologies » speaking at PPMA 2020

Nabil Seidov, Deputy Head Of Department For Health Policy And Planning Of Public Health And Reforms Centre, Ministry of Healthcare of Azerbaijan Republic

Nabil Seidov | Deputy Head Of Department For Health Policy And Planning Of Public Health And Reforms Centre | Ministry of Healthcare of Azerbaijan Republic » speaking at PPMA 2020

Ayman Semaan, Market Access, Algorithm

Ayman Semaan | Market Access | Algorithm » speaking at PPMA 2020

Maja Sercic, Policy & Science Manager, Medicines for Europe

Maja Sercic | Policy & Science Manager | Medicines for Europe » speaking at PPMA 2020

Simon Shohet, Head Of International Market Access, Amicus Therapeutics

Simon Shohet | Head Of International Market Access | Amicus Therapeutics » speaking at PPMA 2020

Rita Shorjian, Market Access Head - Near East And North West Africa, AbbVie

Rita Shorjian | Market Access Head - Near East And North West Africa | AbbVie » speaking at PPMA 2020

Tamir Singer, Head Of Commercial Development, Specialised Commissioning, NHS England

Tamir Singer | Head Of Commercial Development, Specialised Commissioning | NHS England » speaking at PPMA 2020

Sebastian Soluch, Head Of Market Access And Pricing, Europe, Stemline Therapeutics Inc

Sebastian Soluch | Head Of Market Access And Pricing, Europe | Stemline Therapeutics Inc » speaking at PPMA 2020

Ulf Staginnus, Senior Vice President, Head Of Global Market Access And Pricing, Ipsen Pharma

Ulf Staginnus | Senior Vice President, Head Of Global Market Access And Pricing | Ipsen Pharma » speaking at PPMA 2020

Richard Stephens, Patient Advocate, Independant

Richard Stephens | Patient Advocate | Independant » speaking at PPMA 2020

Lotte Steuten, Vice President And Head Of Consulting, Office of Health Economics

Lotte Steuten | Vice President And Head Of Consulting | Office of Health Economics » speaking at PPMA 2020

Magdi Stino, Product Manager, EVERSANA

Magdi Stino | Product Manager | EVERSANA » speaking at PPMA 2020

Luqman Tariq, Market Access Director, Europe, Stryker Corp

Luqman Tariq | Market Access Director, Europe | Stryker Corp » speaking at PPMA 2020

Samuel Taylor, Emerging Markets Pricing Lead, Pfizer

Samuel Taylor | Emerging Markets Pricing Lead | Pfizer » speaking at PPMA 2020

Renske Ten Ham, Researcher, Utrecht University

Renske Ten Ham | Researcher | Utrecht University » speaking at PPMA 2020

Bharat Tewarie, Executive Vice President And Chief Marketing Officer, UCB

Bharat Tewarie | Executive Vice President And Chief Marketing Officer | UCB » speaking at PPMA 2020

David Thompson, Senior Vice President, Head Of Thought Leadership, Real World And Late Phase Research, Syneos Health

Gwilym Thompson, Director, Markets, Health Economics And Outcomes Research, Bristol-Myers Squibb

Gwilym Thompson | Director, Markets, Health Economics And Outcomes Research | Bristol-Myers Squibb » speaking at PPMA 2020

Daria Tolkacheva, Head Of Health Economics, JSC BIOCAD

Daria Tolkacheva | Head Of Health Economics | JSC BIOCAD » speaking at PPMA 2020

Jorg Tomeczkowski, Head Of Market Access, Janssen Cilag Germany

Jorg Tomeczkowski | Head Of Market Access | Janssen Cilag Germany » speaking at PPMA 2020

Oleksandr Topachevskyi, Essential Medicines List Committee Member, Ministry of Health of Ukraine

Oleksandr Topachevskyi | Essential Medicines List Committee Member | Ministry of Health of Ukraine » speaking at PPMA 2020

Jasim Uddin, Head of Evidence, Value & Access, Consulting at McCann Health

Jasim Uddin | Head of Evidence, Value & Access | Consulting at McCann Health » speaking at PPMA 2020

Sheela Upadhyaya, Associate Director Hst, National Institute for Health and Care Excellence

Sheela Upadhyaya | Associate Director Hst | National Institute for Health and Care Excellence » speaking at PPMA 2020

Inneke Van De Vijver, Strategic Advisor - Reimbursement Pharmaceuticals, N.I.H.D.I.

Inneke Van De Vijver | Strategic Advisor - Reimbursement Pharmaceuticals | N.I.H.D.I. » speaking at PPMA 2020

Erik Van Den Berg, Chief Executive Officer, A.M. Pharma

Erik Van Den Berg | Chief Executive Officer | A.M. Pharma » speaking at PPMA 2020

Bart Van Den Daele, Head Of External Affairs - Director Market Access, Gilead Sciences

Bart Van Den Daele | Head Of External Affairs - Director Market Access | Gilead Sciences » speaking at PPMA 2020

Goedele Van Haasteren, Hta Specialist, Swiss Federal Office of Public Health

Evert Jan Van Lente, Director Eu-Affairs, AOK Bundesverdand

Evert Jan Van Lente | Director Eu-Affairs | AOK Bundesverdand » speaking at PPMA 2020

Stefan Vegter, Market Access Manager, Novartis

Stefan Vegter | Market Access Manager | Novartis » speaking at PPMA 2020

Kart Veliste, Chief Specialist At Department Of Medicines And Medical Devices, Haigekassa Estonia

Kart Veliste | Chief Specialist At Department Of Medicines And Medical Devices | Haigekassa Estonia » speaking at PPMA 2020

Marijn Verhoef, Engagement Manager, Access to Medicine Foundation

Marijn Verhoef | Engagement Manager | Access to Medicine Foundation » speaking at PPMA 2020

Bart Vermeulen, Deputy Director Healthcare At Office Of The Minister Of Social Affairs And Public Health, Belgian Federal Government

Bart Vermeulen | Deputy Director Healthcare At Office Of The Minister Of Social Affairs And Public Health | Belgian Federal Government » speaking at PPMA 2020

Jaume Vidal, Policy Advisor, Eu Projects, Health Action International

Jaume Vidal | Policy Advisor, Eu Projects | Health Action International » speaking at PPMA 2020

Reg Waldeck, Market Access Strategy Leader, Bayer Corp

Reg Waldeck | Market Access Strategy Leader | Bayer Corp » speaking at PPMA 2020

Rebecca Walker, Director, Global Access Strategy, UCB Pharma

Rebecca Walker | Director, Global Access Strategy | UCB Pharma » speaking at PPMA 2020

Amy Wang, Managing Consultant, Navigant – A Guidehouse Company

Amy Wang | Managing Consultant | Navigant – A Guidehouse Company » speaking at PPMA 2020

David Watson, Executive Director, Economic, Health and Commercial Policy, ABPI

David Watson | Executive Director, Economic, Health and Commercial Policy | ABPI » speaking at PPMA 2020

Keith White, Vice President And Head, Global Market Access, Corbus Pharmaceuticals

Keith White | Vice President And Head, Global Market Access | Corbus Pharmaceuticals » speaking at PPMA 2020

Anne Willemsen, Project Manager Eunethta, Zorginstituut Nederland / EUnetHTA

Anne Willemsen | Project Manager Eunethta | Zorginstituut Nederland / EUnetHTA » speaking at PPMA 2020

Natasa Zibelnik, Global Head Of Market Access, EUSA Pharma

Natasa Zibelnik | Global Head Of Market Access | EUSA Pharma » speaking at PPMA 2020

Martine Zimmermann, Global Head Of Regulatory Affairs, Alexion Pharmaceuticals

Martine Zimmermann | Global Head Of Regulatory Affairs | Alexion Pharmaceuticals » speaking at PPMA 2020

Fabrizio Zucca, Director Market Access Dach, Intercept Pharmaceuticals Inc

Fabrizio Zucca | Director Market Access Dach | Intercept Pharmaceuticals Inc » speaking at PPMA 2020

 

 

Contact us

To sponsor or exhibit:
Edmond Rama
+44 (0)207 092 1052

edmond.rama@terrapinn.com

To speak:
Chris Shanks
+44 (0)207 092 1151

chris.shanks@terrapinn.com